Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
42
CLDX Quote, Financials, Valuation and Earnings
Last price:
$26.81
Seasonality move
:
15.7%
Day range:
$26.39 - $26.95
52-week range:
$14.40 - $30.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
685.06x
P/B ratio:
2.98x
Volume:
221.2K
Avg. volume:
762.9K
1-year change:
6.76%
Market cap:
$1.8B
Revenue:
$7M
EPS (TTM):
-$3.38
Earnings Data
Next earnings date for CLDX
Feb 26
2026
Most recent earnings per share
-$1.01
Missed by $0.11
(Nov 10/2025)
Consensus Estimate
-$0.90
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CLDX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $1.5M | -- | -- | -$0.99 | -- |
| 11/10/2025 | Q3 | $1.1M | -- | -$1.01 | -$0.90 | -$0.11 |
| 08/08/2025 | Q2 | $1.1M | $730K | -$0.85 | -$0.84 | -$0.01 |
| 05/12/2025 | Q1 | $1.1M | $695K | -$0.81 | -$0.74 | -$0.07 |
| 02/27/2025 | Q4 | $1.3M | $1.2M | -$0.71 | -$0.71 | $0.00 |
| 10/28/2024 | Q3 | $1.1M | $3.2M | -$0.64 | -$0.67 | $0.04 |
| 08/08/2024 | Q2 | $854.3K | $2.5M | -$0.54 | -$0.59 | $0.05 |
| 05/06/2024 | Q1 | $816.7K | $156K | -$0.56 | -$0.67 | $0.12 |
| 02/26/2024 | Q4 | $855.7K | $4.1M | -$0.83 | -$0.67 | -$0.16 |
| 11/02/2023 | Q3 | $583.3K | $1.5M | -$0.81 | -$0.66 | -$0.15 |
| 08/08/2023 | Q2 | -- | $268K | -$0.65 | -- | -- |
| 05/04/2023 | Q1 | -- | $967K | -$0.62 | -- | -- |
| 02/28/2023 | Q4 | -- | $1.6M | -$0.56 | -- | -- |
| 11/09/2022 | Q3 | -- | $407K | -$0.57 | -- | -- |
| 08/08/2022 | Q2 | -- | $163K | -$0.77 | -- | -- |
| 05/05/2022 | Q1 | -- | $174K | -$0.49 | -- | -- |
| 02/28/2022 | Q4 | -- | $334K | -$0.43 | -- | -- |
| 11/09/2021 | Q3 | -- | $153K | -$0.45 | -- | -- |
| 08/05/2021 | Q2 | -- | $3.5M | -$0.34 | -- | -- |
| 05/06/2021 | Q1 | -- | $685K | -$0.42 | -- | -- |
| 03/26/2021 | Q4 | -- | $3.8M | -$0.55 | -- | -- |
| 11/05/2020 | Q3 | -- | $668K | -$0.36 | -- | -- |
| 08/06/2020 | Q2 | -- | $236K | -$0.50 | -- | -- |
| 05/06/2020 | Q1 | -- | $2.7M | -$0.73 | -- | -- |
| 03/26/2020 | Q4 | -- | $887K | -$0.64 | -- | -- |
| 11/12/2019 | Q3 | -- | $546K | -$0.75 | -- | -- |
| 08/07/2019 | Q2 | -- | $715K | -$0.84 | -- | -- |
| 05/07/2019 | Q1 | -- | $1.4M | -$1.40 | -- | -- |
| 03/07/2019 | Q4 | -- | $1.8M | -$0.81 | -- | -- |
| 11/07/2018 | Q3 | -- | $941K | -$0.66 | -- | -- |
| 08/08/2018 | Q2 | -- | $2.8M | -$1.65 | -- | -- |
| 05/10/2018 | Q1 | -- | $4.1M | -$12.60 | -- | -- |
| 03/07/2018 | Q4 | -- | $3.5M | -$0.45 | -- | -- |
| 11/07/2017 | Q3 | -- | $3.9M | -$3.00 | -- | -- |
| 08/08/2017 | Q2 | -- | $3.8M | -$3.45 | -- | -- |
| 05/09/2017 | Q1 | -- | $1.5M | -$4.20 | -- | -- |
| 03/14/2017 | Q4 | -- | $1.9M | -$4.50 | -- | -- |
| 11/07/2016 | Q3 | -- | $2.2M | -$4.35 | -- | -- |
| 08/08/2016 | Q2 | -- | $1.4M | -$4.80 | -- | -- |
| 05/05/2016 | Q1 | -- | $1.3M | -$5.25 | -- | -- |
| 02/25/2016 | Q4 | -- | $1.8M | -$4.95 | -- | -- |
Celldex Therapeutics, Inc. Earnings Questions
-
How Much did Celldex Therapeutics, Inc. Generate in Revenue Last Quarter?
Celldex Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Celldex Therapeutics, Inc. Beat Earnings Last Quarter?
Celldex Therapeutics, Inc. announced earnings per share of -$1.01 which represents a miss of analyst forecast a -$0.90 per share.
-
Is Celldex Therapeutics, Inc. Profitable?
Celldex Therapeutics, Inc. reported -$824K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Celldex Therapeutics, Inc. EPS Next Year?
Celldex Therapeutics, Inc.'s earnings are forecast to decrease from -$2.45 per share to -$2.35 per share next year representing a decrease of -45.87%.
-
When is Celldex Therapeutics, Inc.'s Earnings Date?
Celldex Therapeutics, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
